A Novel Signature of Lipid Metabolism-Related Gene Predicts Prognosis and Response to Immunotherapy in Lung Adenocarcinoma
Background: Lipid metabolism disorder, a new hallmark of cancer initiation, has been involved in lung adenocarcinoma (LUAD). However, few biomarkers about lipid metabolism-related genes (LMRGs) have been developed for prognosis prediction and clinical treatment of LUAD patients.Methods: In this stud...
Main Authors: | Kai Zhang, Ying Qian, Xiaowei Quan, Tengteng Zhu, Biyun Qian |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-02-01
|
Series: | Frontiers in Cell and Developmental Biology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcell.2022.730132/full |
Similar Items
-
Cuproptosis-related signature predicts prognosis, immunotherapy efficacy, and chemotherapy sensitivity in lung adenocarcinoma
by: Gujie Wu, et al.
Published: (2023-03-01) -
A novel signature predicts prognosis and immunotherapy in lung adenocarcinoma based on cancer-associated fibroblasts
by: Qianhe Ren, et al.
Published: (2023-05-01) -
A novel immune checkpoints-based signature to predict prognosis and response to immunotherapy in lung adenocarcinoma
by: Nan Sun, et al.
Published: (2022-07-01) -
Identification of lung adenocarcinoma subtypes and predictive signature for prognosis, immune features, and immunotherapy based on immune checkpoint genes
by: Linbin Hua, et al.
Published: (2023-05-01) -
Development and validation of polyamines metabolism-associated gene signatures to predict prognosis and immunotherapy response in lung adenocarcinoma
by: Ning Wang, et al.
Published: (2023-06-01)